DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Mono Pharmacare Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·15 Oct 2026, 9:48 am

Mono Pharmacare

Mono Pharmacare Limited has submitted a certificate to the stock exchange under SEBI's Depositories and Participants Regulations, 2018. This regulatory filing is a standard requirement for companies to confirm their compliance with the rules governing shareholding patterns and depository services.

For investors, this announcement is largely procedural and does not indicate any immediate operational changes or financial news. It serves as a formal confirmation that the company is adhering to the regulatory framework set by the Securities and Exchange Board of India.

Investors should monitor the company's future disclosures for any material updates. While this specific filing is routine, it reinforces the importance of staying informed about regulatory compliance as part of a broader investment strategy.